Centene names Daniel Finke group president of markets and commercial segment

Reuters04-06
Centene names Daniel Finke group president of markets and commercial segment
  • Centene created two new group president roles reporting to CEO Sarah London.
  • Daniel Finke hired as Group President, Markets and Commercial to oversee Medicaid and Commercial segments; he previously served as CEO of Convey Health Solutions.
  • Finke previously was EVP at CVS Health, serving as President of Aetna with responsibility spanning Medicare, Medicaid, commercial insurance.
  • Michael Carson appointed Group President, Medicare and Specialty with expanded oversight of Medicare Advantage, Part D, dual-eligible, specialty businesses; he joined Centene in January 2024 as Wellcare Medicare CEO.
  • Carson previously served as CEO of Bright HealthCare, Harvard Pilgrim Health Care, CareAbout.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Centene Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202604060700PR_NEWS_USPR_____CG26949) on April 06, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment